The 3^rd Microbiome Movement – Gut-Brain Axis Summit is returning to Boston this December and will unite pioneering industry and academic researchers to establish the mechanistic pathways contributing to neurological disorder manifestation, overcome the scientific and translational challenges of working in the gut-brain setting and capitalize on this therapeutic opportunity.

This meeting provides the opportunity for you to:

• Discover pioneering preclinical data implicating metabolic, immune-mediated and enteroendocrine pathways in CNS disease development
• Explore translational approaches that are moving microbiome gut-brain axis science from association to causation
• Learn about critical considerations for microbiome clinical trials in the neurological and mental health setting to inform symptom and treatment management
• Realize the potential of microbial profiles as a biomarker for patient stratification to maximize the efficacy of already existing drugs for neurological disease
• Uncover the relatively untapped commercial opportunity held by nutritional and therapeutic products for neurological and mental health

There is no question that the early market activity in the microbiome gut-brain axis space is critical in shaping its success. Join us to discover the microbiome science contributing to neurological disease and develop the next generation of microbiome-targeted products for improved neurological and mental health outcomes.

Find out more here: https://ter.li/t9gsy7